dimethyl sulfoxide

EC 200-664-3

Also known as methyl sulfoxide and DMSO.

Latest news on dimethyl sulfoxide

25 September 2026

Johnson & Johnson: CARVYKTI single infusion achieved five-year treatment-free remissions in 50% of early-line RRMM patients

Single CARVYKTI infusion produced treatment-free, progression-free remissions at five years in half of early-line relapsed/refractory multiple myeloma patients.